首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿托伐他汀钙对动脉粥样硬化患者血浆hs-CRP、NO水平的影响
引用本文:李军.阿托伐他汀钙对动脉粥样硬化患者血浆hs-CRP、NO水平的影响[J].医药论坛杂志,2007,28(22):24-26.
作者姓名:李军
作者单位:郑州大学第一附属医院,郑州市,450052
摘    要:目的 研究阿托伐他汀钙对动脉粥样硬化(AS)患者血浆高敏C-反应蛋白(hs-CRP)和一氧化氮(NO)的影响.方法 选择40例正常人作为对照组,40例动脉粥样硬化患者作为试验组,对动脉粥样硬化患者给予阿托伐他汀钙1个月干预治疗,测定治疗前后hs-CRP和NO水平,并与正常对照组比较.结果 动脉粥样硬化组治疗前血浆hs-CRP明显(P<0.01)高于正常对照组,NO明显(P<0.01)低于正常对照组;给予阿托伐他汀钙治疗后血浆hs-CRP降低(P<0.05);血浆NO升高(P<0.05).结论 阿托伐他汀钙对动脉粥样硬化患者具有独立于降脂作用之外的抗炎作用.

关 键 词:动脉粥样硬化  高敏C反应蛋白  一氧化氮  阿托伐他汀钙  阿托伐他汀  动脉粥样硬化  患者  血浆  水平  影响  Acute  Coronary  Syndrome  Patient  Plasma  Levels  Calcium  Atorvastatin  抗炎作用  降脂作用  治疗前后  结果  比较  正常对照组  测定  干预治疗
文章编号:1672-3422(2007)22-0024-03
修稿时间:2007年9月7日

Intervention of Atorvastatin Calcium on Levels of NO and hs - CRP of Plasma of Patient with Acute Coronary Syndrome
LI Jun.Intervention of Atorvastatin Calcium on Levels of NO and hs - CRP of Plasma of Patient with Acute Coronary Syndrome[J].Journal of Medical Forum,2007,28(22):24-26.
Authors:LI Jun
Abstract:Objective To investigate the effects of atorvastatin calcium on hs-CRP and NO of patients with acute coronary syndrome. Methods Experimental set with 40 patients with acute coronary were treated for one month under the intervention of atorvastatin calcium. Measured the level of hs-CRP and NO before and after treatment,and compared with the comparative set with 40 normal people. Results Hs-CRP of plasma of experimental set was stronger than that of comparative set(P<0.01)before treatment,while NO of experimental set was lower than that of comparative set(P<0.01). Hs-CRP of plasma lowered (P<0.05)and NO grew (P<0.05) after treatment with atorvastatin calcium. Conclusion Except lowering serum,atorvastatin calcium has the action of anti-inflammation to patient with acute coronary syndrome.
Keywords:Acute coronary syndrome  High-sensitivity C-reactive protein  NO  Atorvastatin calcium
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号